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Abstract 
 
Intravascular devices with engineered sharps injury protection (ESIP) are 
designed to reduce sharps injuries, but have not been investigated for blood splatter 
potential. In this laboratory-based experiment, which did not use human subjects, 100 
intravenous catheters of the same type with a retraction mechanism, were tested for blood 
splatter. Once blood was obtained from a simulated brachial vein containing mock 
venous blood, the devices were placed in a testing chamber and scientific filters labeled 
A, B & C were used to capture blood splatter after activation. The blood splatter was 
examined visually and microscopically, and the filters were weighed pre- and post-
activation on an analytical scale. The research questions in this study were: 1) do 
retractable intravenous devices produce blood splatter, and 2) does blood splatter 
frequency differ between visual methods vs. microscopy?  
The differences in filter mass, visual inspection, and microscopic analysis for 
presence of blood on filters were the units of analysis. Descriptive statistics, paired t-tests 
to determine pre and post activation filter weights and kappa statistics to assess degree of 
agreement between methods were used to analyze the data. For filters B and C, the 
proportions with blood detected by the naked eye were 12 and 13% respectively. 
However, for filter A, both visual and microscopic methods detected blood splatter on  
iv 
	  70% and 71% of the time respectively. In addition, a statistically significant difference 
was observed in the mean mass of filter A between pre- and post-activation confirmed by 
the naked eye (t= - 0.0013, p= 0.01400) and confirmed microscopically (t= - 0.00014, 
p=0.0092). Substantial agreement between methods was observed for filter A 
(kappa=0.78; 95% CI: 0.64-0.92), filter B (kappa= 0.73; 95% CI: 0.51-0.95) and filter C 
(kappa= 0.75; 95% CI: 0.55-0.96). However, in 7 instances (7%), blood was detected by 
microscopy but not by the naked eye on filters A (5 %), B (1%), and C (1%), 
respectively.  Also, in 6 instances (6%), blood was detected by the naked eye but now by 
microscopy on filter B (3%), and filter C (3%). Consequently, there is potential for a total 
of 13 % blood splatter. 
The findings indicate potential for bloodborne pathogen exposure with use of a 
specific retractable intravascular catheter. The finding that blood splatter was detected by 
microscopy in 7% of the instances has important occupational health implications. 
Healthcare workers (HCWs) may not be able to detect this blood splatter when it occurs 
and may not report a splash to mucous membranes or non-intact skin. This study 
therefore reinforces the need for HCWs to wear personal protective equipment, such as 
masks, face shields, goggles, when using intravascular catheters with retractable 
mechanisms. It is recommended that the research protocol used in this study be replicated 
by other investigators and tested on all brands of retractable intravascular devices. 
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Introduction 
 
 The quantity and wide range use of devices with engineered sharps injury 
protection (ESIP) by all health care workers (HCWs) makes it absolutely necessary to 
explore every conceivable approach of potential bloodborne pathogen exposure and 
transmission, including the possibility of blood to aerosolize due to activation of safety 
mechanism of these devices. The present study was designed to evaluate the safety of 
retractable intravascular devices in terms of their potential to produce blood splatter.  
 
Risk to Health Care Workers 
In the last few decades, multiple diseases due to bloodborne pathogens have 
emerged bearing serious effects on infected persons who come in contact with infected 
blood (blood of person with the disease). One group at a high risk for exposure is the 
health care worker (HCW). HCWs, due to the nature of their occupation, are in constant 
contact with patients’ blood and other body fluids. Consequently, they have been 
identified to be at high-risk for bloodborne pathogen exposure, transmission, and 
infection from hepatitis B virus (HBV), hepatitis C virus (HCV), and human 
immunodeficiency virus (HIV). It is estimated that 385,000 cases of occupational 
exposure to bloodborne pathogens from needlestick and sharps injuries are reported 
annually for hospital based healthcare workers (CDC-Sharps Safety 2010, and Panlilio, 
	  
2	  
	  
et. al. 2004). Furthermore, after a needlestick injury (NSI), the risk of infection ranges 
from 6% to 30% for HBV, 1.0% to 10.0% for HCV with an average of 1.8% , and an 
average of 0.3% per percutaneous injury for HIV (CDC-NIOSH 2000). Also, the risk for 
HIV infection after an exposure to mucous membranes is estimated to be around 0.09% 
(CDC-NIOSH 2000).  In addition to the above mentioned viruses, more than 20 other 
bloodborne pathogens can be transmitted via NSI (CDC-Sharps Safety 2010).   
 
History of Regulations 
In the era when devices were not designed with engineered sharps injury 
protection (ESIPs), NSIs were a major cause of health care worker exposures to 
bloodborne pathogens (CDC-NIOSH 2000). To protect HCWs from bloodborne 
pathogens due to NSIs, the Centers for Disease Control and Prevention (CDC) published 
a list of recommended Universal Precautions in 1987 (CDC 1987). Later on, in 
November of 2000, the US congress passed the Needlestick Safety & Prevention Act 
(NSPA, House of Representatives, and CDC-NIOSH 2000). This was followed by the 
subsequent 2001 revision of the Occupational Safety and Health Administration’s 
(OSHA) Bloodborne Pathogens Standard (BPS). The OSHA BPS requires employers to 
provide devices with ESIP for all HCWs, and their use has significantly reduced the risk 
of NSIs (Panlilio, et. al. 2004). Prior to the implementation of the state and federal laws 
for the use these safety devices, just 15% of US hospitals were practicing with this type 
of the devices (Foley & Leyden 2005). Since the Needlestick Safety & Prevention Act, 
commercial ESIP devices were brought to the market with the aim of reducing the risk of 
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NSIs to HCWs. One of these of devices is an intravenous catheter with a retractable 
mechanism, with one specific brand being tested in this study. 
 
Research on Exposure to Blood Splatter 
Criteria used for the evaluation of ESIP devices efficacy include minimization of 
both the incidence of NSIs and the exposure/transmission of bloodborne pathogens to 
HCWs (Foley & Leyden 2005, and Haiduven, et. al. 2009). However, even though ESIP 
devices may protect from needlestick injuries, they may not protect from exposure to 
bloodborne pathogens. The safety activation of the device may cause blood splatter, 
which is the microaerosolization of blood (Haiduven, et.al. 2009). Taylor (1990) 
indicated that mucous membranes of the face and none-intact skin are potential portals 
for transmission of bloodborne pathogen from miniscule amounts of infected blood. In 17 
out of 20 cases the blood splatter occurred and in some cases, the amounts were invisible 
to the naked eye. This suggests that any amount of blood splatter can pose a potential 
health risk and more importantly if it occurs in aerosol form. 
Review of the studies on health care workers and the use of devices with ESIP 
indicate that blood splatter does occur when ESIP devices are activated, and the mucus 
membranes and non-intact skin are potential paths of transmission.  As a result, some 
HCWs have contracted bloodborne pathogens while using these devices.  
A study of 43 HCW exposed to bloodborne pathogens conducted in Poland from 
2001 to 2004 found that HCWs were exposed to HBV, HCV, and HIV. Thirty-four (34) 
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of these injuries were by needlestick, and four (4) cases due to splash on the skin and 
conjunctiva, while performing procedures. The rest of the injuries were due to other types 
of sharp. This study indicated that from all these cases one HCW was treated for HBV 
and four (4) were being observed due to HCV (Dancewicz, et.al. 2005).  
A report from Australia, based on research carried out from 1998-2003 
retrospectively, indicates 931 HCWs out of 2200 HCWs were exposed to blood and body 
fluid. The study found that sharp injuries and activation of safety intravascular devices 
resulted in 594 of percutaneous and 337 mucocutaneous cases of exposed HCWs to blood 
and body fluid splatter (Bi, et.al, 2006). Another study from Turkey indicated that HCWs 
exposed to blood splatter on their conjunctiva from infected patients with HCV were at 
risk for developing the disease (Hosoglu et.al, 2003). This study mentioned one 
confirmed case of infection with HCV due to blood splatter to the mucous membranes 
during in a hemodialysis unit. Wines et. al. (2008) also indicated that mucocutaneous and 
transconjunctival exposure remains as routs for the transmission of bloodborne pathogens 
to HCWs. The study that included 118 cases indicated that a modern forensic method was 
used to detect blood splash not visible by the naked eye during procedures performed by 
the HCWs. The study found evidence of positive blood splash in 84.2% even in video 
laparoscopic procedures. Furthermore, this study recommends use of personal protective 
equipment (PPE) by all HCWs while performing procedures in all healthcare sittings. 
Based on anecdotal reports from HCWs in the field and the potential risk of blood 
exposure from intravascular devices with retractable mechanisms, Haiduven, et.al (2009) 
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designed a laboratory study to evaluate the potential of blood splatter. They conducted 
pilot testing of several different devices in order to develop methods for the measurement 
of blood splatter. More specifically, they studied three types of retractable intravascular 
devices: two phlebotomy devices (a vacuum tube device and a winged butterfly device) 
and a retractable IV catheter with a retractable mechanism. They tested one hundred of 
each of the devices using an injectable extended antecubital fossa (ACF) pad attached to 
a blood bag containing mock venous blood. They used filters to collect the blood splatter 
when the devices were activated. They found a significant difference in the weight of the 
filters before and after activation for the IV catheter and the winged butterfly set due to 
blood splatter.  Results for the vacuum tube device were equivocal.  
A recent report from England (Ford & Phillips, 2011) found that when three 
different intravascular devices with safety mechanisms were tested [two with needle 
shields Eclipse (Becton Dickinson), and Quick Shield (Greiner Bio-One)] and one with a 
retractable needle [Push Button (Becton Dickinson)] used for blood evacuation), the 
HCWs in the study reported blood splatter. The researchers then tested simulated blood 
with the same devices (twenty of each type) and placed a colored paper underneath the 
device. The researchers confirmed via an ultraviolet light that there was blood splatter in 
areas close to the activation of the safety system. The author confirmed that all 3 types of 
devices caused blood splatter on activation. The study reported that the frequency of 
blood droplets from Eclipse was eight out of 20 (40%), 2 out of 20 for Quick Shield 
(10%), and for the Push Button, the frequency was 7 out of 20 (35%). These laboratory 
studies confirm that there is a potential for occupational exposure to bloodborne 
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pathogens for the HCW associated with the activation of intravascular devices with 
retraction mechanisms that were originally designed to avoid needlestick injuries. These 
results support the need for the use of personal protective equipment to protect the 
mucous membranes and skin of HCWs when they are performing intravascular 
procedures with such devices.  
 
Hypotheses 
To build on the work of Haiduven, et.al. (2009), the present study investigated a 
different type of automatic retractable intravascular device (the Becton Dickinson Insyte 
Autoguard). An activation assembly chamber was designed for this experiment in a 
attempt to capture of all possible blood splatter onto several filters located in the 
immediate vicinity. The study tested not only the difference in filter weight before and 
after activation of the retraction mechanism on the device in order to confirm the 
previous results, but also compared the visibility of blood splatter by the naked eye vs. 
microscopic examination using Cohen's kappa statistics that measures the degree of 
agreement between categorical judgments (i.e., “yes” vs. “no”).   
A review of the literature yielded no results on other studies that used the 
microscope as an instrument to detect blood splatter from the activation of retractable 
safety mechanisms. Nonetheless, the microscope has been an innovative and useful tool 
for bloodstain pattern analysis during criminal investigation when it is necessary to use 
small stains that are difficult to measure. A study by Valkiūnas et al. (2008) compared 
parasitic prevalence information obtained by both microscopy and polymerase chain 
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reaction and showed that both methods yielded similar results, reinforcing the notion that 
microscopy is a reliable tool that is relatively inexpensive, provides valuable information, 
and is unlikely to result in false positives.  In this study, the microscopic examination was 
being used to demonstrate that there is blood splatter even when the HCW cannot 
perceive its presence. 
The research questions in this study were: 1) do retractable intravascular devices 
produce measurable blood splatter; and 2) does blood splatter frequency differ between 
visual methods vs. microscopy? The hypotheses were: 1) there will be a significant 
difference in the mean mass of the filters used to detect blood splatter at three different 
locations before and after activation of the intravascular device; and 2) the presence of 
blood splatter on the filters can be seen by microscopic examination even if not visible to 
the naked eye.  
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Research Methods 
 
In this section, the following will be presented: an overview of the research 
methods in this study, a description of the testing materials and how they were used, an 
explanation of the testing protocol, a description of the data collected and the statistical 
analyses performed. 
 
Methods Overview 
In this experiment, which did not use human subjects, 105 intravenous catheters 
with a retraction mechanism were tested for blood splatter. The experiment was 
conducted in a controlled laboratory environment designed to simulate the environment 
of the health care setting. The study was performed inside two separate tissue culture 
hoods, which provided a controlled environment free from contamination and any sudden 
changes in airflow.  
Injectable extended antecubital fossa (ACF) pads that simulate the human brachial 
vein were attached to a mock venous blood bag consistently containing 500 ml and 
infusion tubing. The retractable intravascular device being tested was inserted into an 
injection site in the ACF pad to simulate and serve the purposes of use in humans in 
healthcare sittings. After insertion, each retractable device was placed in a testing 
chamber and activated. Scientific filters were placed in the activation chamber and used 
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to capture blood spatter after activation. For identification purposes, the three filters were 
denoted as Filter A, Filter B, and Filter C based on their location and use at different 
points of the activation chamber. Filter A was located inside the activation chamber’s 
cylinder, to capture splatter from around the activation mechanism, Filter B was located 
anterior to the device to capture splatter from the tip of the needle, and Filter C was used 
to wipe the device, the researcher’s gloves, and the back section after device activation.  
The weights of the three scientific filters used for each retractable intravascular 
device were measured pre- and post-activation by an analytical scale and recorded on a 
spreadsheet. Before recording any weights, it was ensured that the scale was zeroed with 
the specimen receptacle attached. All filters were visually and microscopically inspected 
pre-activation for the integrity of the filter and the presence of foreign materials, and 
post-activation for the presence of visible blood. Digital microscopic photographs were 
taken of any visible blood. Findings were recorded for each of the parameters as a 
dichotomous outcome (“Y” [Yes] was assigned to denote the detection of visible blood, 
and “N” [No] where blood was not detected.). The presence or absence of mock venous 
blood by either the naked eye or the microscopic examination of each of the filters, and 
the difference in filter mass before and after device activation, were the primary units of 
analysis for detecting blood splatter.  Data were recorded on an EXCEL spreadsheet and 
triple data checking was performed to record each measurement. 
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Retractable Intravascular Device 
In this study, 105 retractable intravascular devices were tested. The retractable 
intravascular safety device that was tested was Becton Dickinson’s Insyte Autoguard, 
with a 2 0 gauge 1.1 X 25mm needle, and an automated mechanism that, when activated, 
rapidly retracts the needle into its barrel, as shown in Figure 1. 
 
 
  
 
 
Figure 1. Retractable intravascular device (Becton Dickinson, 2011). Retrieved from 
http://www.vitalitymedical.com/intravenous-shielded-catheter-infusion-sets-insyte-
autoguard-by-bd-becton-dickinson.html  
 
The specific protocol developed for this study was based on the retraction 
mechanism, its activation, and the manufacturer’s instructions for use. Activation was 
defined as the motion resulting in retraction of the needle itself from its own plastic 
cannula into the barrel of the device as seen in Figure 1 (device post activation).  
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Antecubital Fossa (ACF) Pad and Mock Venous Blood 
Two injectable extended antecubital fossa (ACF) pads (a soft tissue pad that 
simulates the antecubital fossa of the human’s right arm and was used for venipuncture 
and the introduction of cannulae; Limbs & Things, Bristol, UK) were attached to a blood 
bag containing mock venous blood and infusion tubing as displayed in Figure 2.  
 
	     
 
Figure 2. ACF pad in the tissue culture hood.  
Note: Pad is attached to a mock venous blood bag (left upper corner) and infusion tubing.  
 
The mock venous blood used in this experiment, was an artificial blood simulant 
with the same color and viscosity of human venous blood. Two intravenous catheters 
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were inserted into the ACF pad. One catheter was inserted into the top portion of the pad 
(blood entrance site) and the other catheter was inserted into the distal end of the venous 
system of the ACF pad (venous blood exit site). The injection pad was supplied with a 
continuous flow of mock venous blood from a 500 mL supply bag connected to the 
catheter at the proximal end via intravenous tubing with an on/off flow clamp. The 
supply of blood was monitored and adjusted as necessary in order to keep the volume 
between 400-500 mL. The catheter at the distal end was connected to an empty supply 
bag to maintain a continuous flow system and served as a collection system for the mock 
venous blood as it exited the ACF pad. The amount of mock venous blood that moved 
into the device on each insertion was not measured. For this experiment a total of 15 
mock venous blood bottles (250 ml each) were used.  
As shown in Figure 3, each ACF pad was pre-marked and numbered with 50 
insertion sites (1-50 and 51-100, respectively; an additional 5 sites were tested on a third 
pad). A sequence pattern was established so that the insertion sites into the 3 simulated 
veins were not consecutively placed. Each new insertion site was not adjacent to the 
previous insertion site; rather the sites rotated in location, as shown in Figure 4. However, 
each of the ACF pads was pre-marked with the same pattern to minimize the threat of 
misclassification. 
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Figure 3. ACF pad pre-marked and numbered for each insertion site. 
Note: This is a smart site infusion set from Cardinal Health, with continuous blood source 
and receptacle for the artificial blood. 
 
An absorbent pad (cotton on one side and plastic on the other) was placed on the 
ACF pad above and below each insertion site to provide additional protection and prevent 
any seepage that could occur. Stomahesive tape was used to cover each insertion site 
after the device and the number were removed from the previous numbered insertion site 
of the ACF pad. The reasons for this were: 1) to prevent excess seepage from the 
insertion site, and 2) to avoid entering the same insertion site twice. 
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Figure 4. Close up view of the insertion sites on the ACF pad. 
 
Activation Chamber 
The terms “Activation Chamber or Assembly Chamber” were used 
interchangeably to represent a custom-designed apparatus to hold the retractable 
intravascular device for the purpose of device activation, the detection of blood splatter at 
the activation site and the immediate vicinity. “Activation Chamber” was used to collect 
any blood splatter resulting from activation of the device after the catheter was removed 
from the ACF pad but before the needle was retracted into its barrel, as shown in Figure 
5.   
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AFigure 5. Retractable intravascular device positioned in activation chamber 
 
Scientific Filters   
Over three hundred scientific filters composed of Kimberly Clark heavy duty 
coverall particulate arrester material, tested at greater than 0.3 microns, pre-labeled 1-X, 
were used to capture blood splatter from the retracting devices positioned at different 
points inside of the activating chamber. The scientific filters were designated filter A, 
filter B, and filter C. Filter A was positioned inside and around the activation chamber’s 
cylinder and filter B was positioned anterior to the retractable intravascular device (see 
Figure 6). Filter C was used to wipe the back section of the chamber, the glove, and the 
outside of the intravascular device. 
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a.
 b. 
Figure 6. Filters A and B in the assembly chamber.  
Note: Filter A is shown in a) and filter B is shown in b).  
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Analytical Scale 
As illustrated in Figure 7, an Ohaus Adventure Pro Analytical Scale calibrated to 
1/1000g was used to weigh the filters before and after activation of each device. The 
experiment was conducted inside a tissue culture hood, which provided a controlled 
environment free from contamination and any sudden changes in airflow. A pre-
validation protocol was performed to determine the reliability of the scale. The weights of 
the three scientific filters used for each retractable intravascular device were measured in 
milligrams on the analytical scale and recorded on an Excel spreadsheet. 
 
  
Figure 7. Ohaus adventure pro analytical scale in tissue culture hood.  
 
	  
18	  
	  
Digital Microscope 
For this experiment a stereoscopic microscope with digital camera (Model DC5-
420TH 10x-40x magnification, National Optical & Scientific Instruments, San Antonio, 
Texas; with digital camera: software Motic Image Plus Version 2.0, Richmond, British 
Columbia V6V 2K9 Canada) was used. The filters were divided into 9 areas that allowed 
the viewer to provide a more specific location when describing any material seen during 
the microscopic inspection of the filter as shown in Figure 8 (Areas of the Filter). 
 
  
 
Figure 8:  Division and labeling of nine areas of the filter.                                               
Note: The presence of blood was examined for each area in the microscopic review.  
 
Filter number 
identification here 
herelabel here 
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All the filters were perused with the low power objective (10x) using the pattern 
shown on Figure 9 (a diagram of how to scan the filters pre and post device activation). 
This allows for overlapping of the fields when looking under the microscope, reducing 
the chances of missing an area of the filter. Any suspicious material was further 
examined using the high power objective (40x), and results were recorded in a worksheet 
by the research team using triple data checking.  
 
 
 
 
 
 
      
      
 
 
Figure 9. Diagram of filter scans pre and post device activation. 
 
Blood splatter was photographed with the microscope’s digital camera, with some 
examples shown in Figure 10. The digital pictures were labeled with the filter 
Start Point 
End point 
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identification number, and stored in a computer file that could be accessed for future 
references. 
 
a. 
b. 
Figure 10. Filters with blood splatter. 
Note: Photos a) and b) were photographed with the microscope’s digital camera.  
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Testing Protocol 
Four researchers (R1, R2, R3, and R4) conducted the testing protocol.  The 
researchers included an occupational health resident physician for device insertion and 
activation (R2), biomedical engineer assistant for analytical scale measurement and 
passing of filters (R1), a medical microbiology technician to examine scientific filters 
under the microscope (R4), and an infection prevention and occupational health expert 
who timed the experiment and recorded the data (R3). R1 worked primarily inside the 
tissue culture hood number one with the scale and the filters, while R2 worked inside 
tissue culture hood number two to insert and retract the device, and to activate the device 
in the activation chamber located next to the second tissue culture hood. R1 did all of the 
scale readings. R3 opened the I.V. mock blood flow system, monitored R1 & R2’s 
activities, connected the IV needle to a luer-lock syringe, operated the timer, called the 
steps, recorded data, opened and closed the clamps of the IV tubing, and carried the 
filters to R4. R4 examined the filters under the microscope pre-activation weighing for 
any artifacts and then post-activation weighing for the presence or absence of blood. R1 
used bent forceps to place filters on and off the scale and to hand filter “C” to R2. R1 
used straight forceps to place used filters into microscopy storage bins. R4 used forceps 
to handle all filters. 
A 111-step protocol was developed by the research team. The sections of the 
protocol were as follows:  pre-trial activities; initial filter weights; device preparation, 
insertion & activation; filter visual inspection, weighing, and microscopic inspection; and 
post-trial activities.  In order to collect data for 105 trials (5 trials were excluded but a 
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total of 100 were needed, thus the reason for sequencing up to 105), the steps were 
followed 105 times.  
Before beginning of the experiment each day, each tissue culture hood surface 
and the activation chamber were cleaned out thoroughly. All equipment and supplies 
(filters, syringe materials, scale, injection pad, sharps collection receptacle, sharps 
container and cleaning wipes) were placed inside the work area. Once the work areas and 
inside the tissue culture hoods were completely stocked, the adjustable shield was moved 
to the lowest possible position that allowed R1 and R2 to place both of their arms into the 
work area and to conduct the experiment. All researchers donned lab coats and clean 
gloves.   
 
Pre-Trial Activities 
The analytical scale was zeroed with the attached specimen receptacle, the blood 
bags were checked to ensure 500 cc levels were maintained; sites of insertions were 
prepared and protected from potential contamination.   
 
Initial Filter Weights 
R1 removed appropriately the numbered filters from the unused filter storage bin 
in order (filters A, B, and C). R1 placed each filter on the scale with the numbered, non-
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absorbent side down; then called out the weight as read off the scale and repeated the 
number for verification. In this set of steps, all the filters were handled with a forceps. 
 
Device Preparation, Insertion and Activation 
The company’s instruction for the use of the device and insertion into the vein 
were followed by R2. After inserting one of the devices into a pre-marked site, blood 
return was observed, and the needle removed from the designated vein location on the 
ACF pad without activating the retraction mechanism.  The device was then positioned in 
the activation chamber and the safety mechanism activated. 
 
Filter Visual Inspection, Weighing, and Microscopic Inspection 
R2 thoroughly examined the fingers, palm and back of the inner pair of the gloves 
on the right hand; filter A ; filter B;  filter C, and the back section of the device holder for 
the presence or absence of visible blood and was recorded after verification by R4. The 
scale was zeroed each time prior to weighing each filter by R1. All the filters were 
thoroughly examined under the microscope and the presence and the absence of blood 
were recorded. Filters with the presences of blood were photographed by R3.  
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Post-Trial Activities 
Once all of the filters were examined, each filter was placed in a designated 
temporary container labeled for each filter (A, B, and C). In this period the instruments 
used were cleaned, in preparation for the next trial.  
 
Post-Experiment Activities 
After each 10th time, the balance on the scale was checked and gloves were 
changed. At the end of the day, used filters were placed into storage containers labeled 
separately for “A”, “B”, & “C”. 
  
Statistical Analyses 
The data set encompassed a total of 105 experimental trials on one specific design 
of a retractable intravascular device. Data from five trials were excluded to prevent any 
compromise to the validity, leaving a total of 100 trials were retained for the final 
analysis. The difference in mass of filters A, B, and C (the mass of the filter post-
activation minus the mass of the filter pre-activation) were computed to determine 
whether a change in weight occurred. To determine whether or not the observed mean 
difference was due to blood splatter or merely due to chance, a paired sample t-test was 
conducted to compare the mean weight of each filter pre- and post-activation. 
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Furthermore, the data for detected blood on all of the filters was compared for 
visible blood detected by the naked eye and by the microscope. Because two different 
methods for detecting the presence of blood were utilized, it was necessary to measure 
the magnitude of agreement between the two methods of blood detection for each of the 
300 filters. To determine whether the agreement can be attributed to chance findings, a 
kappa statistic (Landis & Koch, 1997) was calculated to compare the degree of agreement 
between filter examination results with the naked eye versus microscopy with respect to 
the presence of blood for each filter. Tests of hypothesis were two-tailed with a type I 
error rate fixed at 5 percent.  SAS version 9.1 (SAS Institute, Cary, NC) was used to 
perform all analyses. 
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Results 
 
The research questions in this study were: 1) do retractable intravascular devices 
produce measurable blood splatter; and 2) does blood splatter frequency differ between 
visual methods vs. microscopy? The hypotheses are: 1) there will be a significant 
difference in the mean mass of the filters used to detect blood splatter at three different 
locations before and after activation of the intravascular device; and 2) the presence of 
blood splatter on the filters can be observed by microscopic examination even if not 
visible by the naked eye.   
 
Table 1. Frequency and percentage of filters A, B, & C with blood by visible detection 
and microscopic methods based on 100 trials. 
 Visible Blood by Naked 
Eye 
Visible Blood by 
Microscopy 
Filter A Filter 
B 
Filter 
C 
Filter A Filter 
B 
Filter C 
Frequency 
 
70 12 13 71 9 10 
Percent (%) 
 
70.00 12.00 13.00 71.00 9.00 10 
Cumulative Freq 
 
100 100 100 100 100 100 
Cumulative Percent 
(%) 
 
100 100 100 100 100 100 
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Table 1 shows that the proportion of filters with detectable blood examined by the 
naked eye were 70%, 12%, and 13% for filters “A”, “B” and “C” respectively, while 
examination by microscopy showed that the proportion of filters with detectable blood 
were 71%, 9%, and 10% respectively. Compared to filter “A,” a smaller proportion of 
filters “B” and “C” contained detectable blood. Thus, the filter with the highest 
proportion of detected blood using both methods of detection, as compared to the 
remaining filters (B and C), was filter A. Figure 1 illustrates the proportion of filters with 
detected blood through microscopic vs. naked eye examination, for filters A, B & C 
respectively. 
 
	  
 
 
Figure 11. Proportion of filters A, B, and C with detected blood. 
Note: This compares the filters with blood detected by visual vs. microscopic methods. 
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A paired student t-test was used to compute the mean (± standard error) mass 
difference for filters A, B, and C before and after activation. The analysis of the mass 
difference for each filter included only those observations where blood was detected on 
the specified filter by the naked eye or microscopically. Table 2 illustrates the mean 
differences for each filter type by detection method. The results indicate that there was 
negative mass difference for some of filters for both detection methods. 
 
 
Table 2.  Mean mass difference, standard deviation, and confidence intervals by filter 
type and detection method 
 
 
 
 
 
 
 
 
 
 
 
Note: N= number of trials with blood splatter, MD= mean mass difference, SD=      
standard deviation, SE= standard error, CI= confidence interval 
 
 
The statistical significance [p < .05] of the mean mass difference is shown in 
Table 3. Results indicate that the difference between the mean mass of filter A pre-
activation and mean mass post-activation was statistically significant for the proportion 
of filters with detected blood by the naked eye [t= - 0.0013, p= 0.0140] and 
microscopically [t=- 0.00014, p= 0.0092]. However, there was no statistically significant 
	   Visible Blood by Naked Eye	   Visible Blood by Microscopy	  
Filter A Filter B Filter C Filter A	   Filter B	   Filter C 
        N 70 12 13 71 9 10 
     MD -0.00013 0.000025     0.000115     -0.00014 0.000156     0.000200     
SD 0.000431  0.000569     0.000580     0.000447 0.000525     0.000643     
95% CI -0.00023 
-0.00003     
-0.00034 
0.000387 
-0.00024 
0.000466     
-0.00025    
-0.00004     
-0.00025 
0.000559     
-0.00026 
0.000660     
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difference between the mean mass of filters B and C pre- and post-activation for either 
detection method. 
 
Table 3.  Mean mass differences and significance values by filter type and detection 
method 
       Note: MD = Mean mass difference  
          ≠ Mean mass difference of specified filters as assessed by t-test, p<0.05 
       *Analysis of the mean mass difference for each filter was conducted including only 
those observations where blood was detected on the specified filter.  
   
 
The second research question was whether there was a difference in visible blood 
detection by the naked eye vs. microscopic examination. Table 4 shows the percentage of 
agreement between these two methods of detection. The associated frequency data for 
filter A shows that in 66 out of 70 times there was agreement that visible blood was 
present, and 25 out of 30 times there was agreement that visible blood was not present. 
The frequency data for filters B and C shows similar agreement on the presence of visible 
blood (8 out of 12 and 9 out of 13, respectively) and on the absence of visible blood (87 
out of 88, and 86 out of 87, respectively). 
 
 Filter A ≠ 
MD [p-value] 
 Filter B≠ 
MD [p-value] 
Filter C≠ 
MD [p-value] 
 
Naked Eye* 
-0.0013 
[0.0140] 
0.00003 
[0.8818] 
0.0012 
[0.4869] 
Microscopy* -0.00014 [0.0092] 
0.00156 
[0.3997] 
0.0002 
[0.3509] 
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Table 4.  Percentage and frequency of agreement on presence or absence of visible blood 
for filters A, B & C 
        Filter Type                                Presence [Freq]                    Absence [Freq] 
         Filter A                                       94 [66/70]                            83 [25/30]                             
         Filter B                                       67 [8/12]                              99 [87/88]                             
         Filter C                                       69 [9/13]                              99 [86/87]                            
Note: [Freq] = frequency 
 
 
To determine whether the degree of agreement on the presence or absence of 
visible blood between the two methods of examination was significant, a kappa test was 
performed.  A statistically significant kappa indicates that the agreement is better than 
chance. Based on a commonly cited scale, where the possible values range from 0 to 1.0, 
0 equals no agreement and 1.0 indicates perfect agreement. The relationship between the 
statistic and level of agreement is presented in Table 5.  
 
Table 5.  Interpretation of the kappa statistic 
  Kappa  Poor Slight Fair Moderate Substantial Perfect 
0.0 0.20 0.40 0.60 0.80 1.0 
 
 
 
 
 
 
Kappa Agreement 
< 0 Less than chance agreement 
0.01-0.20 Slight agreement 
0.21-0.40 Fair agreement 
0.41-0.60 Moderate agreement 
0.61-0.80 Substantial agreement 
0.81-0.99 Almost perfect agreement 
	  
31	  
	  
Table 6.  Kappa statistic on agreement between methods of blood detection on filters A, 
B, & C 
 
 
 
 
The kappa results for this study are summarized in Table 6. Assessing agreement 
between the two detection methods for the presence of visible blood resulted in a kappa 
statistic of 0.78 [95% CI 0.65-0.92] for filter A, 0.73 [95% CI: 0.51-0.96] for filter B, and 
0.75 [95% CI 0.55-0.96] for filter C. These results show that there is substantial 
agreement between detection methods regarding the presence or absence of visible blood 
for each of the filter types. Furthermore, the confidence intervals show that the degree of 
agreement was statistically significant.  
Despite the overall agreement on the presence of visible blood between methods 
of detection, there were trials that demonstrated that the human eye is not capable of 
detecting all blood splatter. Table 7 provides a comparison of the trials in which there 
was disagreement between the methods of detection. Seven trials did not have visible 
blood detected by the naked eye, but showed evidence of blood splatter under the 
microscope. For filter A, there were five trials where blood was detected solely by the 
microscopic examination, while for filters B and C there was one trial each where blood 
 
                Filter Type 
                  
                 Kappa  [95% CI] 
   Filter A 
 
 .78  [0.65-0.92] 
   Filter B .73  [0.51-0.96] 
   Filter C .75  [0.55-0.96] 
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was detected by microscopic examination. Thus, these results indicate that seven percent 
(7%) of the trials exhibited blood microscopically that was not visible to the naked eye.  
 
Table 7. Comparison of trials showing the presence of visual blood via microscopic 
examination but not the naked eye 
 
Trial 
Number 
Filter A Filter B Filter C 
Naked 
Eye 
Micros 
copy 
Naked 
Eye 
Micros
copy 
Naked 
Eye 
Micros
copy 
6 N Y N N N N 
7 N N N Y N N 
16 N Y N N N N 
53 N Y N N N N 
55 N Y N N N N 
72 N Y N N N N 
102 N N N N N Y 
     Total 
      105# 
0 5 0 1 0 1 
Note: Y= presence of blood, N= no presence of blood. One hundred and five trials were 
completed but five were eliminated due to factors compromising the validity.  
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Discussion 
 
HCWs have been identified to be at high-risk for bloodborne pathogen exposure, 
transmission, and infection from HBV, HCV, and HIV. The results in this study are 
consistent with previous research on such exposures. Several studies have evaluated 
intravascular devices in relation to potential blood splatter to face and mucus membranes 
(Ford & Phillips, 2011; Haiduven et.al, 2009). Taylor (1990) found that mucous 
membranes are potential routes of transmission from miniscule amounts of infected blood. 
In some cases, the amounts were invisible to the naked eye. This suggests that any amount 
of blood splatter can pose a potential health risk, especially if it were to become 
aerosolized. In this study, the scientific filters captured blood splatter that was not 
noticeable by the naked eye but was detected by microscopy in 7% of the instances. In 
another 6% of instances, blood visible to the eye was not evident by microscopy and may 
have been explained by small fibers falling off of the filter in between visual examination 
and microscopic examination. Therefore, a potential of 13 /100 times, blood splatter might 
have occurred to HCWs who may not have been aware of the exposure. HCWs may not be 
able to detect the blood splatter when it occurs and may not report a splash to mucous 
membranes or non-intact skin.	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Prior research has confirmed that HCWs are the one group with the highest risk 
for bloodborne pathogen infection after exposure by NSIs. The risk of infection ranges 
from 6% to 30% for HBV, 1.0% to 10.0% for HCV (with an average of 1.8%), and an 
average of 0.3% per percutaneous injury for HIV (CDC-NIOSH 2000). Also, the risk for 
HIV infection after an exposure to mucous membranes is estimated to be around 0.09% 
(CDC, 2010). Because of this risk, it is necessary to reinforce the need for HCWs to wear 
personal protective equipment, such as masks, face shields, and goggles, when using 
retractable intravascular devices to prevent exposure, transmission, and infection by 
bloodborne pathogens. Furthermore, this study reinforces the need for redesign of the 
device in order to eliminate the potential for blood splatter and exposure of HCWs to 
bloodborne pathogens. 
This study has multiple strengths. First, the presence/absence of blood splatter on 
the filters was confirmed by examination of all filters pre and post activation of the 
intravascular device by a high powered microscope (equipped with digital camera), which 
enhanced validity of the study. This eliminated the potential presence of confounders on 
each filter. Second, the entire experiment was performed under a tightly controlled 
environment to prevent changes in temperature and air flow. Third, once the protocol was 
finalized, it was adhered to strictly in each trial to ensure standardization and strengthen 
internal validity. Fourth, the sample size was greater than for many other studies testing 
blood splatter by retractable intravascular devices. Fifth, a single health care physician 
conducted all the intravascular device insertions in the ACF pad, therefore, eliminating 
variation. Sixth, the entire experiment (material and methods) process was designed to 
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resemble the conditions in a health care facility. Finally, the researcher group included a 
multi- disciplinary team: an MD, a RN- PhD in occupational health, a biomedical engineer 
assistant, a medical microbiology technician, and an MD, PhD in biostatistics. 
This study has a few limitations. First, and probably the most important one, is 
that it was not conducted on human subjects. For humans, device activation would occur 
while the needle is in the vein, whereas in this study, device activation occurred away 
from the site of insertion. The transportation of the device may have resulted in a loss of 
blood droplets. Second, the class of filters used for this experiment to capture blood 
splatter had a large amount of thin fibers on the surface of the filters. The results indicated 
that there was a negative mean mass difference for filter A. The negative mass difference 
might be attributed to several factors. One of these factors is the potential loss of thin 
fibers from the filters during the process of wiping, transporting, and examining the filters. 
Another possible factor is a loss of moisture from the filters during the time period 
between pre and post activation of the device. The blood on the fibers of the filters could 
fall off from the filter due to the thin surface fibers. For these reasons, this study has 
expanded the previous work of Haiduven et al. (2009), in the area of no longer using 
change in mean mass filter weight as a parameter. Rather, the microscope should be used 
to examine the filters. Finally, the protocol did not include a standardized method for 
describing or characterizing the patterns of blood splatter. 
The results of this study provide several implications for future research. Future 
studies could investigate the direction, location, and distance of blood splatter. High-speed 
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photography might be used to represent the motion and location of blood splatter at the 
moment of device activation. This protocol could be replicated by other investigators and 
tested on all brands of retractable devices. Research on human subjects could provide 
information on how device activation affects blood splatter in humans, and whether 
personal protective equipment can eliminate exposure. Furthermore, research could be 
done on potential methods for redesigning ESIP devices to completely eliminate blood 
splatter. 
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